Crossmark Global Holdings’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,910	Closed	-$648K	–	1392
2021 Q3	$648K	Sell	32,910 -150	-0.5%	-$3.14K	0.02%	792
2021 Q2	$727K	Buy	33,060 +180	+0.5%	+$4.01K	0.02%	727
2021 Q1	$782K	Buy	32,880 +170	+0.5%	+$4.54K	0.02%	685
2020 Q4	$856K	Buy	32,710 +10,274	+46%	+$216K	0.02%	613
2020 Q3	$390K	Buy	22,436 +436	+2%	+$6.95K	0.01%	886
2020 Q2	$370K	Buy	22,000 +1,700	+8%	+$23.9K	0.01%	895
2020 Q1	$241K	Hold	20,300	–	–	0.01%	964
2019 Q4	$246K	Buy	20,300 +870	+4%	+$12.1K	0.01%	1233
2019 Q3	$275K	Buy	19,430 +190	+1%	+$2.33K	0.01%	1101
2019 Q2	$215K	Sell	19,240 -870	-4%	-$9.69K	0.01%	1267
2019 Q1	$236K	Sell	20,110 -110	-0.5%	-$1.37K	0.01%	1242
2018 Q4	$270K	Sell	20,220 -14,610	-42%	-$193K	0.01%	1138
2018 Q3	$488K	Buy	34,830 +450	+1%	+$6.29K	0.01%	967
2018 Q2	$540K	Buy	34,380 +2,070	+6%	+$36K	0.01%	895
2018 Q1	$531K	Buy	+32,310	New	+$599K	0.01%	882